A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount"
}
],
"id": "https://med-mastodon.com/users/gpollara/statuses/109834161662337231/replies",
"type": "Collection",
"first": {
"id": "https://med-mastodon.com/users/gpollara/statuses/109834161662337231/replies?page=true",
"type": "CollectionPage",
"next": "https://med-mastodon.com/users/gpollara/statuses/109834161662337231/replies?only_other_accounts=true&page=true",
"partOf": "https://med-mastodon.com/users/gpollara/statuses/109834161662337231/replies",
"items": [
{
"id": "https://med-mastodon.com/users/gpollara/statuses/109834161687600536",
"type": "Note",
"summary": null,
"inReplyTo": "https://med-mastodon.com/users/gpollara/statuses/109834161662337231",
"published": "2023-02-09T09:51:45Z",
"url": "https://med-mastodon.com/@gpollara/109834161687600536",
"attributedTo": "https://med-mastodon.com/users/gpollara",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://med-mastodon.com/users/gpollara/followers"
],
"sensitive": false,
"atomUri": "https://med-mastodon.com/users/gpollara/statuses/109834161687600536",
"inReplyToAtomUri": "https://med-mastodon.com/users/gpollara/statuses/109834161662337231",
"conversation": "tag:med-mastodon.com,2023-02-09:objectId=14212657:objectType=Conversation",
"content": "<p>What are possible implications of our findings? 🤷<br />1) IL-6 antagonists (e.g. tocilizumab) probably do not increase risk of latent ➡️ active TB. <br />2) Too much IL-6 may be a bad thing in TB disease - our recent work suggests a pathological role: <a href=\"https://pubmed.ncbi.nlm.nih.gov/33952677/\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">pubmed.ncbi.nlm.nih.gov/339526</span><span class=\"invisible\">77/</span></a> 4/6</p>",
"contentMap": {
"en": "<p>What are possible implications of our findings? 🤷<br />1) IL-6 antagonists (e.g. tocilizumab) probably do not increase risk of latent ➡️ active TB. <br />2) Too much IL-6 may be a bad thing in TB disease - our recent work suggests a pathological role: <a href=\"https://pubmed.ncbi.nlm.nih.gov/33952677/\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"ellipsis\">pubmed.ncbi.nlm.nih.gov/339526</span><span class=\"invisible\">77/</span></a> 4/6</p>"
},
"attachment": [],
"tag": [],
"replies": {
"id": "https://med-mastodon.com/users/gpollara/statuses/109834161687600536/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://med-mastodon.com/users/gpollara/statuses/109834161687600536/replies?min_id=109834161712566039&page=true",
"partOf": "https://med-mastodon.com/users/gpollara/statuses/109834161687600536/replies",
"items": [
"https://med-mastodon.com/users/gpollara/statuses/109834161712566039"
]
}
},
"likes": {
"id": "https://med-mastodon.com/users/gpollara/statuses/109834161687600536/likes",
"type": "Collection",
"totalItems": 1
},
"shares": {
"id": "https://med-mastodon.com/users/gpollara/statuses/109834161687600536/shares",
"type": "Collection",
"totalItems": 1
}
}
]
}
}